in: PubMed | Google Scholar 1 Department of Medicine, Hematology/Oncology Division, Robert H
The SELECT trial of nearly 18,000 individuals showed that 2.4mg of semaglutide reduced heart attacks, strokes, and mortality due to CVD, with 73% fewer patients progressing to diabetes compared to the control group
Fiuza-Luces C, Santos-Lozano A, Joyner M, Carrera-Bastos P, Picazo O, Zugaza JL, et al
Plant-based ingredients (carrageenan), and alternative sweeteners for balanced wellness
Best noted that doctors could also recommend other GLP-1 drugs such as liraglutide (Victoza, Saxenda) or even explore weight loss drugs that work through different mechanisms like phentermine, bupropion, or naltrexone